Cite
Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis
MLA
Ghoraba, Hashem H., et al. Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1342154554&authtype=sso&custid=ns315887.
APA
Ghoraba, H. H., Matsumiya,Wataru, Khojasteh,Hassan, Akhavanrezayat,Amir, Karaca,Irmak, Or,Christopher, Yavari,Negin, Lajevardi,Sherin, Hwang,Jaclyn, Yasar,Cigdem, Do,Diana, & Nguyen, Q. D. (2022). Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis.
Chicago
Ghoraba, Hashem H, Matsumiya,Wataru, Khojasteh,Hassan, Akhavanrezayat,Amir, Karaca,Irmak, Or,Christopher, Yavari,Negin, et al. 2022. “Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1342154554&authtype=sso&custid=ns315887.